HIGH

Raz-AT (Attendant Tilt) Mobile Shower Commode Chair, Catalog Number Z300 UDI-DI code: (01)00628758003007 Raz-ART (Attendant Rotational Tilt) Mobile Shower Commode Chair, Catalog Number Z333 ...

Due to a modification by a vendor and may be reinstalled without properly engaging the outside rear seat brackets that are used to keep the seat in place.

Quick Facts at a Glance

Recall Date
January 5, 2026
Hazard Level
HIGH
Brand
Raz Design
Geographic Scope
1 states

Hazard Information

Due to a modification by a vendor and may be reinstalled without properly engaging the outside rear seat brackets that are used to keep the seat in place.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Raz Design Inc or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Raz Design recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Raz-AT (Attendant Tilt) Mobile Shower Commode Chair, Catalog Number Z300 UDI-DI code: (01)00628758003007 Raz-ART (Attendant Rotational Tilt) Mobile Shower Commode Chair, Catalog Number Z333 UDI-DI code: (01)00628758003335 Raz-AT600 (Bariatric Tilt) Mobile Shower Commode Chair, Catalog Number Z360 UDI-DI code: (01)00628758003601 Raz-SP (Self Propel) Mobile Shower Commode Chair, Catalog Number Z200 UDI-DI code: (01)00628758001003 Raz-AP (Attendant Propel) Mobile Shower Commode Chair, Catalog Number Z100 UDI-DI code: (01)00628758001003 The Raz Mobile Shower Commode Chair is intended to be used by people with mobility impairments, who may have difficulty in standing or keeping their balance while completing activities such as showering, toileting, or personal hygiene.. Reason: Due to a modification by a vendor and may be reinstalled without properly engaging the outside rear seat brackets that are used to keep the seat in place.. Classification: Class II. Quantity: 66. Distribution: U.S. Nationwide distribution in the states of CO, FL, IL, MA, MI, MN, MO, NC, NE, NH, NJ, NY, OR, PA, TX, WA, and WI.

View Original Recall on FDA - Medical Devices

Browse More Recalls

More from FDA_DEVICEHealth & Personal CareMedical Devices

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Raz-AT (Attendant Tilt) Mobile Shower Commode Chair Catalog Number Z300 Seat Catalog Numbers: ZVFIFAR17 ZVFIFAR20 ZCSEAT (FAR) UDI-DI code: (01)00628758003007 Serial Numbers: RAT218789 RAT116906 RAT200337 RAT208010 RAT208987 RAT210426 RAT211344 RAT211837 RAT211998 RAT212001 RAT212066 RAT212450 RAT213190 RAT213227 RAT214334 RAT217987 RAT218213 RAT218552 RAT218570 RAT218612 RAT219142 RAT220066 RAT222210 RAT223140 RAT224902 RAT206923 RAT217768 RAT221724 RAT213036 RAT218862 RAT221044 RAT216437 RAT217073 RAT218555 RAT218557 RAT219817 RAT121348 RAT216055 RAT217379 RAT220648 RAT124264 RAT200864 Raz-ART (Attendant Rotational Tilt) Mobile Shower Commode Chair Catalog Number Z333 Seat Catalog Numbers: ZVFIFAR17 ZVFIFAR20 ZCSEAT (FAR) UDI-DI code: (01)00628758003335 Serial Numbers: ART219556 ART222544 ART211605 ART223825 ART212722 ART212675 Raz-AT600 (Bariatric Tilt) Mobile Shower Commode Chair Catalog Number Z360 Seat Catalog Numbers: ZCSEATHD (FAR) UDI-DI code: (01)00628758003601 Serial Numbers: BAT216618 BAT204112 Raz-SP (Self Propel) Mobile Shower Commode Chair Catalog Number Z200 Seat Catalog Numbers: ZVFIFAR17 ZVFIFAR20 ZCSEAT (FAR) UDI-DI code: (01)00628758001003 Serial Numbers: RAS210872 RAS214903 RAS217818 RAS220760 RAS209166 RAS218239 RAS107030 RAS214470 Raz-AP (Attendant Propel) Mobile Shower Commode Chair Catalog Number Z100 Seat Catalog Numbers: ZVFIFAR17 ZVFIFAR 20 ZCSEAT (FAR) UDI-DI code: (01)00628758001003 Serial Numbers: RAS217210 RAS224711 RAS214364 FAR Seat (Demo) Catalog Numbers: ZVFI17FAR-A ZCSEAT-A UDI-DI code: N/A Serial Numbers: N/A
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

CRITICAL

Massive Eye Drop Recall Hits CVS, Walgreens, Kroger — 8 Products Never Tested for Sterility (2026)

Millions of eye drop bottles sold at CVS, Walgreens, Kroger, and other major pharmacies may not be sterile. K.C. Pharmaceuticals of Pomona, California never verified that eight of its over-the-counter eye drop products met sterility standards, the FDA warned. A nearly identical manufacturing failure in 2023 left patients blind, cost others their eyes, and killed at least three people. Consumers should stop using the products and return them for a full refund.

CVS Health
Nonsterile eye
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.

OCTREOTIDE ACETATE
Lack of
Read more
HIGH

Straumann USA Recalls 13 Custom Abutment Ti RC for TAN Material Mix-Up (2026)

Straumann USA recalled 13 Custom Abutment Ti RC units distributed worldwide, including the United States and Canada. A TAN material was misidentified as Titanium Ti Gr4 D during manufacturing, causing RC Titanium abutments to be made from TAN material. Clinics and patients should stop using the devices immediately and follow recall instructions from Straumann USA or their healthcare providers.

Straumann USA
A material
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)

Teva Pharmaceuticals USA recalled 19,869 cartons of Octreotide Acetate for Injectable Suspension nationwide in the United States after FDA inspection flagged lack of assurance of sterility at the contract manufacturer. The FDA cited quality system deficiencies at Pharmathen International S.A. in Greece. Healthcare providers and patients should stop using the product immediately and contact Teva or

OCTREOTIDE ACETATE
Lack of
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall Expanded in 2026 for Sterility Concerns

Teva Pharmaceuticals recalled 1,897 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the USA after an FDA inspection flagged sterility concerns. The recall is due to lack of assurance of sterility from the contract manufacturer. Consumers and healthcare providers should stop using the product immediately and contact Teva for guidance.

OCTREOTIDE ACETATE
Lack of
Read more